Search results for "mucin"

showing 10 items of 189 documents

Clinical, dermoscopic, and histologic aspects of two cases of cutaneous focal mucinosis*

2019

Abstract: Cutaneous mucinoses are a complex and diverse group of connective tissue disorders characterized by the accumulation of mucin and/or glycosaminoglycan in the skin and adnexa. Cutaneous focal mucinosis appears as a solitary, asymptomatic, skin-colored to white papule, nodule, or plaque located anywhere on the body or in the oral cavity. It presents mainly in adults and is characterized on histopathology by mucin throughout the upper and mid dermis. We describe the dermoscopy of two cases of cutaneous focal mucinosis. Both lesions presented a nonspecific homogenous whitish pattern; the first case also exhibited a sharply demarcated yellow border.

Pathologymedicine.medical_specialtyConnective tissueCase ReportDermoscopyDermatologyOral cavityAsymptomatic030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDermismedicinePathologybusiness.industryMucinNodule (medicine)General Medicinemedicine.diseasemedicine.anatomical_structureCutaneous focal mucinosisSkin abnormalitiesRL1-803030220 oncology & carcinogenesisHistopathologymedicine.symptombusinessAnais Brasileiros de Dermatologia
researchProduct

Limitations of Immunohistochemistry in Diagnosis of a Primary Mucinous Carcinoma of the Skin and Its Metastasis

2020

We describe the case of a 67-year-old female patient who presented with an unclear swelling on the right supraclavicular neck, two years after resection of a mucinous carcinoma on the right mastoid. Two pathological reports from separate universities diagnosed the primary mastoid skin lesion as a metastatic adenocarcinoma. Strikingly, GATA binding protein 3 (GATA3) and mammaglobin, both immunomarkers found in breast cancer, were positive. An urgent search for the primary tumor most likely in the breast was commenced. However, as no other primary tumor could be detected at that time, a Primary Mucinous Carcinoma of the Skin (PMCS) was also debated. Two years later neck node enlargement was s…

Pathologymedicine.medical_specialtyContext (language use)ImmunostainingMetastasisLesion030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineMammaglobinBreast cancerDiagnosisCarcinomaMedicineMucinous carcinomabiologybusiness.industryCarcinomaAsploro Journal of Biomedical and Clinical Case ReportsGeneral Medicinemedicine.diseaseImmunohistochemistryPrimary tumor030220 oncology & carcinogenesisbiology.proteinmedicine.symptombusinessAsploro Journal of Biomedical and Clinical Case Reports
researchProduct

Development of polymer-based nanoparticles for Zileuton delivery to the lung : PMeOx and PMeOzi surface chemistry reduces interactions with mucins

2021

In this paper, two amphiphilic graft copolymers were synthesized by grafting polylactic acid (PLA) as hydrophobic chain and poly(2-methyl-2-oxazoline) (PMeOx) or poly(2-methyl-2-oxazine) (PMeOzi) as hydrophilic chain, respectively, to a backbone of α,β-poly(N-2-hydroxyethyl)-D,L-aspartamide (PHEA). These original graft copolymers were used to prepare nanoparticles delivering Zileuton in inhalation therapy. Among various tested methods, direct nanoprecipitation proved to be the best technique to prepare nanoparticles with the smallest dimensions, the narrowest dimensional distribution and a spherical shape. To overcome the size limitations for administration by inhalation, the nano-into-micr…

Poly(2-oxazoline)sPolymers116 Chemical sciencesPharmaceutical ScienceMedicine (miscellaneous)Nanoparticle02 engineering and technology01 natural scienceschemistry.chemical_compoundDrug Delivery SystemsNanoparticlePolylactic acidCopolymerPolyaminesHydroxyureaGeneral Materials SciencePoly(2-oxazine)sDRUG-DELIVERYCells Culturedchemistry.chemical_classificationDrug CarriersCHALLENGESAIRWAY MUCUSPolymer021001 nanoscience & nanotechnologyGraftingDIFFUSIONPolyaspartamidePULMONARY DELIVERYDrug deliveryMolecular Medicine0210 nano-technologyHydrophobic and Hydrophilic Interactionsmedicine.drugLung inflammationPolyestersBiomedical EngineeringINHIBITIONBioengineeringBronchi010402 general chemistryPolylactic acidZileutonAmphiphileAdministration InhalationmedicineHumansPoly(2-oxazoline)RELEASEMucinsBronchial DiseasesEpithelial CellsZileuton0104 chemical scienceschemistryChemical engineeringSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanoparticlesASTHMAPoly(2-oxazine)
researchProduct

Biodegradable and pH-sensitive hydrogels for potential colon-specific drug delivery: Characterization and in vitro release studies

2008

A novel pH-sensitive and biodegradable composite hydrogel, based on a methacrylated and succinic derivative of dextran, named Dex-MA-SA, and a methacrylated and succinic derivative of alpha,beta-poly( N-2-hydroxyethyl)- DL-aspartamide (PHEA), named PHM-SA, was produced by photocross-linking. The goal was to obtain a colon-specific drug delivery system, exploiting both the pH-sensitive behavior and the colon-specific degradability. The hydrogel prepared with a suitable ratio between the polysaccharide and the polyaminoacid was characterized regarding its swelling behavior in gastrointestinal simulated conditions, chemical and enzymatic degradability, interaction with mucin, and cell compatib…

Polymers and PlasticsBiocompatibilityCell SurvivalColonBioengineeringBiomaterialschemistry.chemical_compoundDrug Delivery SystemsSpectroscopy Fourier Transform InfraredMaterials ChemistrymedicineMucoadhesionHumansDextranaseChromatographydextran polyaspartamide colon releaseChemistryMucinsHydrogelsHydrogen-Ion ConcentrationDextranBiochemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliverySelf-healing hydrogelsCaco-2 CellsSwellingmedicine.symptomDrug carrier
researchProduct

Proteomic characterization of the mucosal pellicle formed in vitro on a cellular model of oral epithelium

2020

The oral mucosal pellicle is a thin lubricating layer generated by the binding of saliva proteins on epithelial oral cells. The protein composition of this biological structure has been to date studied by targeted analyses of specific salivary proteins. In order to perform a more exhaustive proteome characterization of pellicles, we used TR146 cells expressing or not the transmembrane mucin MUC1 and generated pellicles by incubation with human saliva and washing to remove unbound proteins. A suitable method was established for the in vitro isolation of the mucosal pellicle by "shaving" it from the cells using trypsin. The extracts, the washing solutions and the saliva used to constitute the…

Proteomics0301 basic medicineSalivaTR146/MUC1 cells[SDV]Life Sciences [q-bio]BiophysicsPluncBiochemistryEpithelium03 medical and health sciencesTandem Mass SpectrometrymedicineHumansDental PellicleSalivary Proteins and PeptidesSalivaproteomicMUC1Mucosal pellicle030102 biochemistry & molecular biologyChemistryMucinTrypsinIn vitroTransmembrane proteinCellular model of oral mucosa030104 developmental biologyBiochemistryProteome[SDV.AEN]Life Sciences [q-bio]/Food and Nutritionmedicine.drugJournal of Proteomics
researchProduct

The role of mucin 1 in respiratory diseases

2020

Recent evidence has demonstrated that mucin 1 (MUC1) is involved in many pathological processes that occur in the lung. MUC1 is a transmembrane protein mainly expressed by epithelial and hematopoietic cells. It has a receptor-like structure, which can sense the external environment and activate intracellular signal transduction pathways through its cytoplasmic domain. The extracellular domain of MUC1 can be released to the external environment, thus acting as a decoy barrier to mucosal pathogens, as well as serving as a serum biomarker for the diagnosis and prognosis of several respiratory diseases such as lung cancer and interstitial lung diseases. Furthermore, bioactivated MUC1-cytoplasmi…

Pulmonary and Respiratory MedicineAnti-Inflammatory Agents03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicinePulmonary fibrosismedicineAnimalsHumansRespiratory systemLung cancerMUC1lcsh:RC705-779Lungbusiness.industryMucinMucin-1lcsh:Diseases of the respiratory systemmedicine.diseaseAsthmaIntracellular signal transductionBiomarkermedicine.anatomical_structure030228 respiratory system030220 oncology & carcinogenesisCancer researchbusinessSignal Transduction
researchProduct

Mucus and MUC in asthma.

2005

Asthma is characterized by chronic airway inflammation and a mucus hypersecretory phenotype comprising excess mucus secretion, goblet cell hyperplasia and submucosal gland hypertrophy. This augmented mucus secretion has been relatively undervalued in asthma compared with airway inflammation. However, mucus plugging contributes to airflow limitation and airway hyperresponsiveness, and to morbidity and mortality in asthma. We review recent contributions to this field and therapeutic avenues to control mucus hypersecretion.A distinct mucus hypersecretory phenotype may present in asthma. Overexpression of MUC5AC, MUC5B and MUC2 have been described in asthma secretions, but identification of def…

Pulmonary and Respiratory MedicineGoblet cell hyperplasiabusiness.industryMucinMucinsRespiratory Mucosarespiratory systemmedicine.diseaseMucusPhenotypeAsthmarespiratory tract diseasesMuscle hypertrophyMucusfluids and secretionsPhenotypeImmunologyChronic DiseaseMedicineHumansSecretionbusinessAirwayAsthmaCurrent opinion in pulmonary medicine
researchProduct

Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways.

2010

Mucus hypersecretion and mucin MUC5AC overexpression are pathological features of chronic obstructive pulmonary disease (COPD). This study examines the inhibitory effect of aclidinium, a new long-acting muscarinic antagonist, on MUC5AC expression in human airway epithelial cells. MUC5AC mRNA (RT-PCR) and protein expression (ELISA and immunohistochemistry) were studied in human bronchial tissue and differentiated human airway epithelial cells activated with carbachol (100 μM) or cigarette smoke extract in the absence or presence of aclidinium. Carbachol increased MUC5AC mRNA and protein expression in human bronchus and cultured epithelial cells. Aclidinium inhibited the carbachol-induced MUC…

Pulmonary and Respiratory MedicineMAPK/ERK pathwaymedicine.medical_specialtyCarbacholRespiratory SystemMuscarinic AntagonistsPharmacologyMucin 5ACPulmonary Disease Chronic ObstructiveDownregulation and upregulationInternal medicinemedicineHumansRNA Small InterferingCells CulturedBronchusbusiness.industryMucinSmokingEpithelial Cellsrespiratory systemMucusEpitheliumErbB ReceptorsEndocrinologymedicine.anatomical_structureCarbacholMitogen-Activated Protein KinasesbusinessTyrosine kinasemedicine.drugTropanesThe European respiratory journal
researchProduct

Cystic mucinous adenocarcinoma of the lung: a case report.

2011

Abstract Mucinous cystic tumors of the lung are uncommon, the preoperative pathologic diagnosis is difficult and their biological behavior is still controversial. We report the case of a patient with a clinically benign cystic lesion that post-operatively showed to be consistent with an invasive adenocarcinoma arising in a mucinous cystadenoma of the lung, We underline the difficulty of the clinical pre-operative diagnosis of this cystic neoplasia radiologically mimicking a hydatid cyst, and we report the negative TTF1 immunostaining potentially misleading in the differential diagnosis with metastatic mucinous carcinomas. Finallly, we evidence the presence of a pre-existing mucinous benign …

Pulmonary and Respiratory MedicinePathologymedicine.medical_specialtyLung NeoplasmsProliferation indexCystic mucinous adenocarcinoma lungSettore MED/21 - Chirurgia Toracicalcsh:SurgeryEnzyme-Linked Immunosorbent AssayCase ReportSettore MED/08 - Anatomia PatologicaMalignant transformationMetastasislcsh:RD78.3-87.3Diagnosis DifferentialFatal OutcomeCystadenoma MucinousBronchoscopymedicineAdenocarcinoma of the lungHumansMucinous cystadenomabusiness.industrylcsh:RD1-811General MedicineMiddle Agedmedicine.diseaseImmunohistochemistrylcsh:AnesthesiologyCystadenomaAdenocarcinomaSurgeryFemaleRadiologyDifferential diagnosisCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedJournal of cardiothoracic surgery
researchProduct

Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays to Evaluate Serum- and Monoclonal-Antibody Specificity

2009

Repetitive Sequences Amino Acidmedicine.drug_classMolecular Sequence DataMonoclonal antibodyCatalysisMiceTandem repeatAntibody SpecificityNeoplasmsmedicineAnimalsAmino Acid SequencePeptide sequenceMUC1biologyMicroarray analysis techniquesChemistryImmune SeraMucin-1GlycopeptidesAntibodies MonoclonalGeneral MedicineGeneral ChemistryMicroarray AnalysisMolecular biologyGlycopeptideBiochemistrybiology.proteinAntibodyDNA microarrayAngewandte Chemie International Edition
researchProduct